{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:16:21Z","timestamp":1783005381186,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1053\/j.ajkd.2005.12.025","type":"journal-article","created":{"date-parts":[[2006,3,28]],"date-time":"2006-03-28T16:05:42Z","timestamp":1143561942000},"page":"644-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Effect of Intravenous Ascorbic Acid in Hemodialysis Patients With EPO-Hyporesponsive Anemia and Hyperferritinemia"],"prefix":"10.1053","volume":"47","author":[{"given":"Nizar","family":"Attallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Osman-Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Frinak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatole","family":"Besarab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 8","key":"10.1053\/j.ajkd.2005.12.025_bib1","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1093\/ndt\/gfh1113","article-title":"Optimizing renal anemia management\u2014Benefits of early referral and treatment","volume":"20","author":"Stevens","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2005.12.025_bib2","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/ndt\/17.suppl_1.13","article-title":"Anaemia management in chronic kidney disease patients","volume":"17","author":"Valderrabano","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 5","key":"10.1053\/j.ajkd.2005.12.025_bib3","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/ndt\/16.suppl_5.45","article-title":"The importance of early treatment of the anaemia of chronic kidney disease","volume":"16","author":"Eknoyan","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 7","key":"10.1053\/j.ajkd.2005.12.025_bib4","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/ndt\/16.suppl_7.25","article-title":"Hyporesponsiveness to recombinant human erythropoietin","volume":"16","author":"Drueke","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2005.12.025_bib5","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1038\/sj.ki.4490858","article-title":"Erythropoietin hyporesponsiveness","volume":"69","author":"Tarng","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ajkd.2005.12.025_bib6","series-title":"2004 Annual Report. Clinical Performance Measures Project.","year":"2004"},{"issue":"suppl 5","key":"10.1053\/j.ajkd.2005.12.025_bib7","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1093\/ndt\/17.suppl_5.38","article-title":"Patient characteristics determining rHuEPO dose requirements","volume":"17","author":"Ifudu","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2005.12.025_bib8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1046\/j.1523-1755.1999.00565.x","article-title":"Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients","volume":"56","author":"Nguyen-Khoa","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.12.025_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000045830","article-title":"Lipophilic antioxidants and iron status in ESRD patients on hemodialysis","volume":"86","author":"Lim","year":"2000","journal-title":"Nephron"},{"key":"10.1053\/j.ajkd.2005.12.025_bib10","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1093\/ndt\/14.11.2680","article-title":"Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy","volume":"14","author":"Lim","year":"1999","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 6","key":"10.1053\/j.ajkd.2005.12.025_bib11","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/ndt\/10.supp6.44","article-title":"Resistance to erythropoietin in iron-overloaded hemodialysis patients can be overcome by ascorbic acid administration","volume":"10","author":"Gastaldello","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2005.12.025_bib12","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/ndt\/13.11.2867","article-title":"A parallel comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in hemodialysis patients with iron overload","volume":"13","author":"Tarng","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2005.12.025_bib13","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1046\/j.1523-1755.1999.00479.x","article-title":"Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia","volume":"55","author":"Tarng","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.12.025_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0272-6386(03)00419-0","article-title":"Effect of ascorbic acid administration in hemodialysis patients on in vitro oxidative stress parameters","volume":"42","author":"Chen","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2005.12.025_bib15","first-page":"703","article-title":"Comparative study of intravenous ascorbic acid versus low-dose desferrioxamine in patients on hemodialysis with hyperferritinemia","volume":"16","author":"Deira","year":"2003","journal-title":"J Nephrol"},{"key":"10.1053\/j.ajkd.2005.12.025_bib16","first-page":"444","article-title":"Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency","volume":"13","author":"Giancaspro","year":"2000","journal-title":"J\u2009Nephrol"},{"key":"10.1053\/j.ajkd.2005.12.025_bib17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0272-6386(03)00356-1","article-title":"Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients","volume":"41","author":"Keven","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2005.12.025_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1081\/JDI-120021157","article-title":"Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload","volume":"25","author":"Lin","year":"2003","journal-title":"Ren Fail"},{"key":"10.1053\/j.ajkd.2005.12.025_bib19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1525-1594.2002.06888.x","article-title":"Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients","volume":"26","author":"Sezer","year":"2002","journal-title":"Artif Organs"},{"key":"10.1053\/j.ajkd.2005.12.025_bib20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1523-1755.2005.00183.x","article-title":"Intravenous iron preparations and ascorbic acid","volume":"67","author":"Sturm","year":"2005","journal-title":"Kidney Int"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2005.12.025_bib21","first-page":"S192","article-title":"DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure","volume":"30","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2005.12.025_bib22","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/ndt\/14.suppl_2.50","article-title":"Is there a role for adjuvant therapy in patients being treated with epoetin?","volume":"14","author":"Horl","year":"1999","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 4","key":"10.1053\/j.ajkd.2005.12.025_bib23","first-page":"S20","article-title":"European Best Practice Guidelines 6\u20138","volume":"15","author":"Macdougall","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2005.12.025_bib24","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1523-1755.2004.00480.x","article-title":"Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients","volume":"65","author":"Canavese","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.12.025_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0272-6386(03)00915-6","article-title":"Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients","volume":"42","author":"Kalantar-Zadeh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2005.12.025_bib26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0272-6386(97)90104-9","article-title":"Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO","volume":"30","author":"Mittman","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2005.12.025_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5414\/CNP59115","article-title":"Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients","volume":"59","author":"Tsuchiya","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2005.12.025_bib28","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1046\/j.1523-1755.2001.00078.x","article-title":"Evaluating iron sufficiency","volume":"60","author":"Besarab","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2005.12.025_bib29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1681\/ASN.V113530","article-title":"Optimization of epoetin therapy with intravenous iron in hemodialysis patients","volume":"11","author":"Besarab","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2005.12.025_bib30","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/ndt\/gfh136","article-title":"Low-dose continuous iron therapy leads to a positive iron balance and decreased serum transferrin levels in chronic haemodialysis patients","volume":"19","author":"Canavese","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2005.12.025_bib31","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood-2003-03-0807","article-title":"Labile plasma iron in iron overload","volume":"102","author":"Esposito","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2005.12.025_bib32","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0006-2952(99)00040-4","article-title":"Role of ascorbic acid in transferrin-independent reduction and uptake of iron by U-937 cells","volume":"57","author":"May","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/j.ajkd.2005.12.025_bib33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0304-4165(80)90028-8","article-title":"Rapid mobilization of ferritin iron by ascorbate in the presence of oxygen","volume":"631","author":"Bienfait","year":"1980","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.ajkd.2005.12.025_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2141.1959.tb04020.x","article-title":"The enzymic formation of heme by the incorporation of iron into protoporphyrin","volume":"5","author":"Goldberg","year":"1959","journal-title":"Br J Haematol"},{"key":"10.1053\/j.ajkd.2005.12.025_bib35","doi-asserted-by":"crossref","first-page":"16046","DOI":"10.1016\/S0021-9258(17)33971-6","article-title":"Uptake of non-transferrin-bound iron by both reductive and non-reductive processes is modulated by intracellular iron","volume":"269","author":"Randell","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ajkd.2005.12.025_bib36","doi-asserted-by":"crossref","first-page":"19540","DOI":"10.1074\/jbc.270.33.19540","article-title":"Ascorbic acid enhances ferritin mRNA translation by an IRP\/Aconitase switch","volume":"270","author":"Toth","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ajkd.2005.12.025_bib37","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/ndt\/gfh260","article-title":"Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis","volume":"19","author":"Deicher","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 8","key":"10.1053\/j.ajkd.2005.12.025_bib38","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/ndt\/17.suppl_8.29","article-title":"C-Reactive protein, a marker of all-cause and cardiovascular mortality in hemodialysis patients","volume":"17","author":"Wanner","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2005.12.025_bib39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1492-7535.2004.01085.x","article-title":"Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients","volume":"8","author":"Yao","year":"2004","journal-title":"Hemodialysis Int"},{"key":"10.1053\/j.ajkd.2005.12.025_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cccn.2005.02.026","article-title":"Principal component analysis of some oxidative stress parameters and their relationships in hemodialytic and transplanted patients","volume":"358","author":"Antolini","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1053\/j.ajkd.2005.12.025_bib41","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bbrc.2005.07.035","article-title":"The structure and function of oxidized albumin in hemodialysis patients","volume":"334","author":"Mera","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.ajkd.2005.12.025_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1081\/JDI-49533","article-title":"Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients","volume":"27","author":"Shi","year":"2005","journal-title":"Ren Fail"},{"key":"10.1053\/j.ajkd.2005.12.025_bib43","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/j.arrt.2003.09.002","article-title":"Trace elements and vitamins in maintenance dialysis patients","volume":"10","author":"Kalantar-Zadeh","year":"2003","journal-title":"Adv Ren Replace Ther"},{"key":"10.1053\/j.ajkd.2005.12.025_bib44","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/ndt\/gfh928","article-title":"Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients","volume":"20","author":"Fumeron","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2005.12.025_bib45","first-page":"262","article-title":"Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation","volume":"67","author":"Bohm","year":"1997","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1053\/j.ajkd.2005.12.025_bib46","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7326\/0003-4819-82-4-460","article-title":"Oxidative injury to erythrocytes, cell rigidity, and splenic hemolysis in hemodialyzed uremic patients","volume":"82","author":"Rosenmund","year":"1975","journal-title":"Ann Intern Med"},{"issue":"suppl 5","key":"10.1053\/j.ajkd.2005.12.025_bib47","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1093\/ndt\/16.suppl_5.40","article-title":"Novel aspects of erythropoietin response in renal failure patients","volume":"16","author":"Sunder-Plassmann","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2005.12.025_bib48","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/ajcn\/23.10.1339","article-title":"Ascorbic acid depletion in patients undergoing chronic hemodialysis","volume":"23","author":"Sullivan","year":"1970","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.ajkd.2005.12.025_bib49","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0891-5849(97)00391-2","article-title":"The molecular pathobiology of cell membrane iron","volume":"24","author":"Browne","year":"1998","journal-title":"Free Radic Biol Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638605019438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638605019438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:44:56Z","timestamp":1759455896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638605019438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0272638605019438"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2005.12.025","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Intravenous Ascorbic Acid in Hemodialysis Patients With EPO-Hyporesponsive Anemia and Hyperferritinemia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2005.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2006.01.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}